Avalo Therapeutics Inc

Stock Chart, Company Information, and Scan Results

$11.68(as of Sep 25, 10:24 AM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Avalo Therapeutics Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$11.68
Ticker SymbolAVTX
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees23
CountyUSA
Market Cap$148.0M

Avalo Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development of therapies for the treatment of immune dysregulation in the Unites States. Its lead asset includes AVTX-009, a humanized monoclonal antibody that binds to interleukin-1ß, which is in phase 2 clinical trial to treat inflammatory diseases. The company was formerly known as Cerecor Inc. and changed its name to Avalo Therapeutics, Inc. in August 2021. Avalo Therapeutics, Inc. was incorporated in 2011 and is headquartered in Rockville, Maryland.

Avalo Therapeutics Inc In Our Stock Scanner

As of Sep 25, 2025
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
As of ---
As of ---
example chart graphic
Scan Name: Cup and HandleScan Type: Chart Pattern Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.